Molecular endophenotypes of H1 and H2 MAPT haplotypes
Molecular endophenotypes of H1 and H2 MAPT haplotypes
批准号:
9762819
负责人:
Karen H Ashe
金额:
$19.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2020-04-30
关键词:
AffectAgeAgingAmericanAnimal ModelBiologicalBiological AssayChronicDevelopmentDiseaseEtiologyGene ClusterGenesGenetic PolymorphismGenomeGoalsHandHaplotypesHumanKnowledgeLate Onset Alzheimer DiseaseLocationMAPT geneMeasuresMedicalMessenger RNAMethodologyModelingMolecularMolecular TargetMusOdds RatioPathologicPathway interactionsPatternProgressive Supranuclear PalsyProteinsReportingRiskRisk FactorsStructureTauopathiesUntranslated RNAVariantage relateddisorder riskendophenotypegene replacementgenetic risk factorgenetic variantgenome wide association studyhigh riskin vivo BioassayinsightmRNA Expressionmouse genomemouse modelpreservationprotective effectprotein expressiontau Proteinstau dysfunctiontau phosphorylationtherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Our long-term goal is to understand the biological mechanisms underlying GWAS hits in LOAD and
other tauopathies. The objective of our current proposal is to develop mouse models in which the
entire 190 Kb human MAPT gene precisely replaces the complete 157 Kb mouse Mapt gene, and to
use these models to compare the molecular endophenotypes of tau in young and old mice expressing
H2 or H1 MAPT haplotypes. Our rationale is that the non-coding variants that define the H1 and H2
haplotypes are present in MAPT but not Mapt, necessitating the incorporation of the full MAPT gene. In
addition, because we have found that the location of MAPT in the mouse genome affects its
expression, we will preserve the basic structural configuration of Chr17q21.31 in which MAPT resides,
and maintain its relationship relative to other genes in the gene cluster that mice and humans share.
These studies will be significant because they will constitute the first in vivo bioassays of non-coding
polymorphisms, paving the way for future research on GWAS hits in not only LOAD, but also other
chronic medical disorders. Our overarching hypothesis is that differences in the progression and
pattern of tau mRNA and protein expression underlie the variations in risk associated with H2 and H1
MAPT haplotypes.
We have in-hand the first MAPT Gene-Replacement (GR) mouse line, in which the 190kb human H2
MAPT precisely replaces the 157 Kb Mapt locus, and will use the same methodology to create a
precisely matched line in which the H1 MAPT replaces Mapt. We will measure and compare mRNA,
protein and post-translational modifications of tau in young and old GR1 and GR2 mice.
Upon completion of these studies, we will have created and characterized two lines of mice in which
Mapt is precisely replaced by H1 or H2 variants of MAPT. We predict that the distinct polymorphisms in
H1 and H2 MAPT will suffice to alter the molecular endophenotype of tau in GR1 relative to GR2 mice,
and that these differences will increase with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics
-
批准号:10761291
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2023
-
负责人:Karen H Ashe
-
依托单位:
Caspase-2 Probe Compounds
-
批准号:10532777
-
项目类别:
-
资助金额:$70.96万
-
财政年份:2019
-
负责人:Karen H Ashe
-
依托单位:
Caspase-2 Probe Compounds
-
批准号:10322438
-
项目类别:
-
资助金额:$71.04万
-
财政年份:2019
-
负责人:Karen H Ashe
-
依托单位:
Caspase-2 Probe Compounds
-
批准号:9974861
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2019
-
负责人:Karen H Ashe
-
依托单位:
Role of Tau Cleavage in Tauopathy
-
批准号:8798702
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2013
-
负责人:Karen H Ashe
-
依托单位:
Role of Tau Cleavage in Tauopathy
-
批准号:8503061
-
项目类别:
-
资助金额:$41.14万
-
财政年份:2013
-
负责人:Karen H Ashe
-
依托单位:
Role of Tau Cleavage in Tauopathy
-
批准号:8617878
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2013
-
负责人:Karen H Ashe
-
依托单位:
Role of Tau Cleavage in Tauopathy
-
批准号:8999021
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2013
-
负责人:Karen H Ashe
-
依托单位:
Improved Transgenic Mouse Model of Alzheimer's Disease
-
批准号:8244853
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Karen H Ashe
-
依托单位:
Improved Transgenic Mouse Model of Alzheimer's Disease
-
批准号:8413428
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Karen H Ashe
-
依托单位:
Specific amyloid-beta oligomer aptamers
-
批准号:7937928
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2009
-
负责人:Karen H Ashe
-
依托单位:
Specific amyloid-beta oligomer aptamers
-
批准号:7815825
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2009
-
负责人:Karen H Ashe
-
依托单位:
In Search of the Molecular Basis of Memory Loss in Tauopathy
-
批准号:7678928
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2008
-
负责人:Karen H Ashe
-
依托单位:
In Search of the Molecular Basis of Memory Loss in Tauopathy
-
批准号:7514358
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2008
-
负责人:Karen H Ashe
-
依托单位:
In Search of the Molecular Basis of Memory Loss in Tauopathy
-
批准号:8025924
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2008
-
负责人:Karen H Ashe
-
依托单位:
The Biology of Alzheimer's Disease in Transgenic Mice
-
批准号:7118110
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2004
-
负责人:Karen H Ashe
-
依托单位:
The Biology of Alzheimer's Disease in Transgenic Mice
-
批准号:7473182
-
项目类别:
-
资助金额:$50.84万
-
财政年份:2004
-
负责人:Karen H Ashe
-
依托单位:
The Biology of Alzheimer's Disease in Transgenic Mice
-
批准号:6950460
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2004
-
负责人:Karen H Ashe
-
依托单位:
The Biology of Alzheimer's Disease in Transgenic Mice
-
批准号:7273551
-
项目类别:
-
资助金额:$50.37万
-
财政年份:2004
-
负责人:Karen H Ashe
-
依托单位:
The Biology of Alzheimer's Disease in Transgenic Mice
-
批准号:6951105
-
项目类别:
-
资助金额:$50.07万
-
财政年份:2004
-
负责人:Karen H Ashe
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: